Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00397
Species: Homo sapiens
Position : chr14:23437399-23439399
Year: 2021
Title: Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: cardiomyopathy
PMID:  33478249
MONDO: MONDO:0004994
Tissue: heart
Tissue Ontology ID: UBERON:0000948
Cell Source: human induced pluripotent stem cell-derived cardiomyocytes
Cell Type: cardiac muscle cell
Cell Ontology ID: CL:0000746
Experiment Type: Enhancer variant functional assay; endogenous enhancer deletion; target-gene expression; cardiac phenotype; Chromatin interaction assay; Disease-variant functional analysis
High Throughput Method: ATAC-seq; H3K27ac profiling; promoter-capture chromatin conformation analysis; Capture-C
Low Throughput Method: CRISPR/Cas9 enhancer deletion; TBX5 motif analysis; gene-expression assay; engineered heart tissue contractility assay
About Target Gene
Target gene : MYH7
About TF
TF name : TBX5
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
TBX5 Physiological factors reactome 12
TBX5 YAP1- and WWTR1 (TAZ)-stimulated gene expression reactome 29
TBX5 Hs_Heart_Development_WP1591_90186 wikipathways 28
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer